• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones.需氧和厌氧环境对五种氟喹诺酮类药物抗葡萄球菌活性的影响
Antimicrob Agents Chemother. 1995 Feb;39(2):507-12. doi: 10.1128/AAC.39.2.507.
2
Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin.司帕沙星(CI-978;AT-4140)、氧氟沙星和环丙沙星的抗葡萄球菌活性。
Antimicrob Agents Chemother. 1990 Sep;34(9):1843-5. doi: 10.1128/AAC.34.9.1843.
3
Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.通过体外药效学系统评估替马沙星对脆弱拟杆菌的活性。
Antimicrob Agents Chemother. 1993 Nov;37(11):2454-8. doi: 10.1128/AAC.37.11.2454.
4
In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.司帕沙星及其他三种氟喹诺酮类药物对耐甲氧西林金黄色葡萄球菌和表皮葡萄球菌的体外活性
Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):55-8. doi: 10.1007/BF01971273.
5
Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.环丙沙星、氧氟沙星、司帕沙星、替马沙星、CI-960、CI-990和WIN 57273对厌氧菌的比较活性。
Antimicrob Agents Chemother. 1992 May;36(5):1158-62. doi: 10.1128/AAC.36.5.1158.
6
Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin.氟喹诺酮类药物CI-960、PD 131628、司帕沙星、氧氟沙星和环丙沙星的抗葡萄球菌活性。
Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):168-71. doi: 10.1007/BF01964451.
7
Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
Antimicrob Agents Chemother. 1991 Dec;35(12):2562-7. doi: 10.1128/AAC.35.12.2562.
8
In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628.环丙沙星以及新型氟喹诺酮类药物克林沙星(CI-960)和PD 131628吞噬细胞内生物活性的体外研究。
Chemotherapy. 1993 Nov-Dec;39(6):424-31. doi: 10.1159/000238988.
9
Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.环丙沙星、氧氟沙星、司帕沙星和曲伐沙星对葡萄球菌和链球菌的杀菌动力学
Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):816-9. doi: 10.1007/s100960050199.
10
Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).对新型氟喹诺酮类药物DU-6859a与六种结构相似的化合物(环丙沙星、克林沙星、氟罗沙星、左氧氟沙星、氧氟沙星和司帕沙星)进行交叉耐药性分析。
Diagn Microbiol Infect Dis. 1995 Jan;21(1):51-4. doi: 10.1016/0732-8893(94)00116-e.

引用本文的文献

1
Underscoring interstrain variability and the impact of growth conditions on associated antimicrobial susceptibilities in preclinical testing of novel antimicrobial drugs.强调新抗菌药物临床前试验中菌株间变异性和生长条件对抗菌药物敏感性的影响。
Crit Rev Microbiol. 2019 Feb;45(1):51-64. doi: 10.1080/1040841X.2018.1538934. Epub 2018 Dec 6.
2
Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of staphylococci in an in vitro model under aerobic and anaerobic conditions.在需氧和厌氧条件下的体外模型中,三种新型氟喹诺酮类药物对六种葡萄球菌菌株的比较药效学研究。
Antimicrob Agents Chemother. 2002 May;46(5):1561-3. doi: 10.1128/AAC.46.5.1561-1563.2002.
3
Bactericidal activity and postantibiotic effect of levofloxacin against anaerobes.左氧氟沙星对厌氧菌的杀菌活性及抗生素后效应
Antimicrob Agents Chemother. 1999 Oct;43(10):2547-9. doi: 10.1128/AAC.43.10.2547.
4
Use of newer quinolones for the treatment of intraabdominal infections: focus on clinafloxacin.新型喹诺酮类药物在腹腔内感染治疗中的应用:聚焦于克林沙星
Infection. 1999 May-Jun;27(3):166-72. doi: 10.1007/BF02561522.
5
MIC-based interspecies prediction of the antimicrobial effects of ciprofloxacin on bacteria of different susceptibilities in an in vitro dynamic model.基于最低抑菌浓度(MIC)的环丙沙星对体外动态模型中不同敏感性细菌抗菌作用的种间预测
Antimicrob Agents Chemother. 1998 Nov;42(11):2848-52. doi: 10.1128/AAC.42.11.2848.
6
Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors.P-糖蛋白抑制剂可改变人肠道Caco-2细胞系中司帕沙星的分泌。
Antimicrob Agents Chemother. 1998 Oct;42(10):2607-11. doi: 10.1128/AAC.42.10.2607.
7
DNA gyrase, topoisomerase IV, and the 4-quinolones.DNA 回旋酶、拓扑异构酶IV与4-喹诺酮类药物。
Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92. doi: 10.1128/mmbr.61.3.377-392.1997.
8
Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect.通过时间杀菌动力学和抗生素后效应研究证明BAY 12 - 8039对革兰氏阳性和革兰氏阴性菌的药效学特性。
Antimicrob Agents Chemother. 1997 Jun;41(6):1377-9. doi: 10.1128/AAC.41.6.1377.

本文引用的文献

1
Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.金黄色葡萄球菌中由外排介导的氟喹诺酮耐药性。
Antimicrob Agents Chemother. 1993 May;37(5):1086-94. doi: 10.1128/AAC.37.5.1086.
2
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.通过使用抗生素去除珠粒消除喹诺酮类抗生素残留
Antimicrob Agents Chemother. 1993 Jun;37(6):1377-9. doi: 10.1128/AAC.37.6.1377.
3
Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.通过体外药效学系统评估替马沙星对脆弱拟杆菌的活性。
Antimicrob Agents Chemother. 1993 Nov;37(11):2454-8. doi: 10.1128/AAC.37.11.2454.
4
In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.
Am J Med. 1987 Apr 27;82(4A):33-9.
5
Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.鼠伤寒沙门氏菌和大肠杆菌外膜突变体对喹诺酮类药物敏感性的差异。
Antimicrob Agents Chemother. 1986 Mar;29(3):535-8. doi: 10.1128/AAC.29.3.535.
6
Routes of quinolone permeation in Escherichia coli.喹诺酮在大肠杆菌中的渗透途径。
Antimicrob Agents Chemother. 1988 Apr;32(4):438-42. doi: 10.1128/AAC.32.4.438.
7
The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo.氟喹诺酮类药物体外耐药性产生的频率以及使用小鼠肾盂肾炎模型来证明体内耐药性的选择。
J Antimicrob Chemother. 1987 Apr;19(4):449-65. doi: 10.1093/jac/19.4.449.
8
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
9
Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.喹诺酮类抗菌药物抑制DNA回旋酶的机制:一种协同药物-DNA结合模型。
Biochemistry. 1989 May 2;28(9):3886-94. doi: 10.1021/bi00435a039.
10
Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model.使用体外药效学模型评估蛋白结合对达托霉素和万古霉素杀灭金黄色葡萄球菌的影响。
Antimicrob Agents Chemother. 1990 Oct;34(10):1925-31. doi: 10.1128/AAC.34.10.1925.

需氧和厌氧环境对五种氟喹诺酮类药物抗葡萄球菌活性的影响

Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones.

作者信息

Zabinski R A, Walker K J, Larsson A J, Moody J A, Kaatz G W, Rotschafer J C

机构信息

Miles Inc., West Haven, Connecticut 06516, USA.

出版信息

Antimicrob Agents Chemother. 1995 Feb;39(2):507-12. doi: 10.1128/AAC.39.2.507.

DOI:10.1128/AAC.39.2.507
PMID:7726522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC162568/
Abstract

A previously established in vitro pharmacodynamic system was used to evaluate the antistaphylococcal activities of five fluoroquinolones under both aerobic and anaerobic conditions. Staphylococcus aureus ATCC 29213 was exposed to a 5-micrograms/ml concentration of each of the following fluoroquinolones: ciprofloxacin, ofloxacin, temafloxacin, sparfloxacin, and clinafloxacin. Terminal elimination half-lives of 4, 6, 8, 8, and 13 h were simulated for the respective drugs. Each fluoroquinolone was bactericidal under both aerobic and anaerobic conditions. However, the bactericidal activity of each fluoroquinolone was delayed by anaerobiosis. This difference in fluoroquinolone activity under aerobic and anaerobic conditions could not be attributed to any particular parameter or physiochemical property but was most likely caused by a combination of factors (e.g., variations in hydrophobicity, intracellular pH, antibiotic concentration, and structure-activity relationships). Fluoroquinolone uptake studies were also performed to investigate the possibility of active, energy-dependent transport mechanisms in S. aureus ATCC 29213. Uptake studies indicated that active efflux does occur in S. aureus ATCC 29213.

摘要

使用先前建立的体外药效学系统,在需氧和厌氧条件下评估了五种氟喹诺酮类药物的抗葡萄球菌活性。将金黄色葡萄球菌ATCC 29213暴露于以下每种氟喹诺酮类药物5微克/毫升的浓度下:环丙沙星、氧氟沙星、替马沙星、司帕沙星和克林沙星。分别模拟了这几种药物4、6、8、8和13小时的终末消除半衰期。每种氟喹诺酮类药物在需氧和厌氧条件下均具有杀菌作用。然而,厌氧状态会延迟每种氟喹诺酮类药物的杀菌活性。氟喹诺酮类药物在需氧和厌氧条件下活性的这种差异不能归因于任何特定参数或理化性质,而很可能是由多种因素共同作用引起的(例如,疏水性、细胞内pH值、抗生素浓度以及构效关系的变化)。还进行了氟喹诺酮类药物摄取研究,以调查金黄色葡萄球菌ATCC 29213中是否存在主动的、能量依赖性转运机制。摄取研究表明,金黄色葡萄球菌ATCC 29213中确实存在主动外排。